Home / Latest Reports / Canine Arthritis Treatment Market

Canine Arthritis Treatment Market By Treatment Type (Stem Cell Therapy, Non-steroidal anti-inflammatory drugs and Opioids), Route of Administration (Injectable and Oral), and End-Users (Retail Pharmacies, Veterinary Hospitals and Clinics, E-commerce and Drug Stores), - Global Industry Analysis And Forecast To 2027

Published On : August 2018 Pages : 180 Category: Healthcare IT Report Code : HC081195

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook

Arthritis is a degenerative situation that influences number of joints, which can lead to severe pain if not treated. Canine Arthritis is a medical condition that affects one out of five dogs. Causes of Canine Arthritis are; terrible injuries that cause joint imbalance, overweight body (Obesity) increases the force acting on joints, inherently weak or unstable joints and improper development of bones in younger dogs. Canine Arthritis can be noticed in dog with change in the mood and level of daily activity. Canine Arthritis is one of the primary chronic conditions seen in dogs. There is seen a rise in the authorization from FDA regarding the Canine Arthritis Treatment drug and also increase in the development and adoption of stem cell therapy to treat Canine Arthritis. Therefore, the Canine Arthritis Treatment Market is anticipated to expand and has tremendous scope during the forecast period. The global Canine Arthritis Treatment Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Canine Arthritis Treatment Market is based on segment; by Treatment Type the market is segmented into Stem Cell Therapy, Non-steroidal anti-inflammatory drugs and Opioids; by Route of Administration the market is segmented into Injectable and Oral; and by End-Users the market is segmented into Retail Pharmacies, Veterinary Hospitals and Clinics, E-commerce and Drug Stores.

  • Canine Arthritis Treatment Market, By Treatment Type
  • Stem Cell Therapy
  • Non-steroidal anti-inflammatory drugs
  • Opioids
  • Canine Arthritis Treatment Market, By Route of Administration
  • Injectable
  • Oral
  • Canine Arthritis Treatment Market, By End-Users
  • Retail Pharmacies
  • Veterinary Hospitals and Clinics
  • E-commerce
  • Drug Stores

Regional Insights

On a global front, the Canine Arthritis Treatment Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Canine Arthritis Treatment Market, the factors for growth are; rising expenditure on veterinary care and rising demand for related drugs and therapies.

Canine Arthritis Treatment Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Norbrook Laboratories Limited, Zoetis Inc., Vetoquinol S.A., Aratana Therapeutics Inc., Elanco (Eli Lilly and Company), Dechra Pharmaceuticals Plc., Bayer AG, VetStem Biopharma, and Boehringer Ingelheim. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Norbrook Laboratories Limited
  • Zoetis Inc.
  • Vetoquinol S.A.
  • Aratana Therapeutics Inc.
  • Elanco (Eli Lilly and Company)
  • Dechra Pharmaceuticals Plc.
  • Bayer AG
  • VetStem Biopharma
  • Boehringer Ingelheim

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?

Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Canine Arthritis Treatment Market, By Treatment Type, Estimates and Forecast, 2014-2023 ($Million)

o   Stem Cell Therapy

o   Non-steroidal anti-inflammatory drugs

o   Opioids

o   Canine Arthritis Treatment Market, By Route of Administration, Estimates and Forecast, 2014-2023 ($Million)

o   Injectable

o   Oral

o   Canine Arthritis Treatment Market, By End-Users, Estimates and Forecast, 2014-2023 ($Million)

o   Retail Pharmacies

o   Veterinary Hospitals and Clinics

o   E-commerce

o   Drug Stores

Canine Arthritis Treatment Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

o   North America

§  North America Canine Arthritis Treatment Market, By Country

o   U.S. Canine Arthritis Treatment Market

o   Canada Canine Arthritis Treatment Market

o   Mexico Canine Arthritis Treatment Market

o   Europe

§  Europe Canine Arthritis Treatment Market, By Country

o   Germany Canine Arthritis Treatment Market

o   UK Canine Arthritis Treatment Market

o   France Canine Arthritis Treatment Market

o   Russia Canine Arthritis Treatment Market

o   Italy Canine Arthritis Treatment Market

o   Rest of Europe Canine Arthritis Treatment Market

o   Asia-Pacific

§  Asia-Pacific Canine Arthritis Treatment Market, By Country

o   China Canine Arthritis Treatment Market

o   Japan Canine Arthritis Treatment Market

o   South Korea  Canine Arthritis Treatment Market

o   India Canine Arthritis Treatment Market

o   Southeast Asia Canine Arthritis Treatment Market

o   Rest of Asia-Pacific Canine Arthritis Treatment Market

o   South America

§  South America Canine Arthritis Treatment Market, By Country

o   Brazil Canine Arthritis Treatment Market

o   Argentina Canine Arthritis Treatment Market

o   Columbia Canine Arthritis Treatment Market

o   Rest of South America Canine Arthritis Treatment Market

o   Middle East and Africa

§  Middle East and Africa Canine Arthritis Treatment Market, By Country

o   Saudi Arabia Canine Arthritis Treatment Market

o   UAE Canine Arthritis Treatment Market

o   Egypt Canine Arthritis Treatment Market

o   Nigeria Canine Arthritis Treatment Market

o   South Africa Canine Arthritis Treatment Market

o   Rest of MEA Canine Arthritis Treatment Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Canine Arthritis Treatment Market, By Treatment Type

5.1.     Introduction

5.2.     Global Canine Arthritis Treatment Revenue and Market Share by Treatment Type (2017-2027)

5.2.1.  Global Canine Arthritis Treatment Revenue and Revenue Share by Treatment Type (2017-2027)

5.3.     Stem Cell Therapy

5.3.1.  Global Stem Cell Therapy Revenue and Growth Rate (2017-2027)

5.4.     Non-steroidal anti-inflammatory drugs

5.4.1.  Global Non-steroidal anti-inflammatory drugs Revenue and Growth Rate (2017-2027)

5.5.     Opioids

5.5.1.  Global Opioids Revenue and Growth Rate (2017-2027)

6.       Canine Arthritis Treatment Market, By Route Of Administration

6.1.     Introduction

6.2.     Global Canine Arthritis Treatment Revenue and Market Share by Route Of Administration (2017-2027)

6.2.1.  Global Canine Arthritis Treatment Revenue and Revenue Share by Route Of Administration (2017-2027)

6.3.     Injectable

6.3.1.  Global Injectable  Revenue and Growth Rate (2017-2027)

6.4.     Oral

6.4.1.  Global Oral Revenue and Growth Rate (2017-2027)

7.       Canine Arthritis Treatment Market, By End-Users

7.1.     Introduction

7.2.     Global Canine Arthritis Treatment Revenue and Market Share by End-Users (2017-2027)

7.2.1.  Global Canine Arthritis Treatment Revenue and Revenue Share by End-Users (2017-2027)

7.3.     Retail Pharmacies

7.3.1.  Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

7.4.     Veterinary Hospitals and Clinics

7.4.1.  Global Veterinary Hospitals and Clinics Revenue and Growth Rate (2017-2027)

7.5.     E-commerce

7.5.1.  Global E-commerce  Revenue and Growth Rate (2017-2027)

7.6.     Drug Stores

7.6.1.  Global Drug Stores Revenue and Growth Rate (2017-2027)

8.       Canine Arthritis Treatment Market, By Region

8.1.     Introduction

8.2.     Global Canine Arthritis Treatment Revenue and Market Share by Regions

8.2.1.  Global Canine Arthritis Treatment Revenue by Regions (2017-2027)

8.3.     North America Canine Arthritis Treatment by Countries

8.3.1.  North America Canine Arthritis Treatment Revenue and Growth Rate (2017-2027)

8.3.2.  North America Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Canine Arthritis Treatment by Countries

8.4.1.  Europe Canine Arthritis Treatment Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Canine Arthritis Treatment by Countries

8.5.1.  Asia-Pacific Canine Arthritis Treatment Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Canine Arthritis Treatment by Countries

8.6.1.  South America Canine Arthritis Treatment Revenue and Growth Rate (2017-2027)

8.6.2.  South America Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Canine Arthritis Treatment by Countries

8.7.1.  Middle East and Africa Canine Arthritis Treatment Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Norbrook Laboratories Limited

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Zoetis Inc.

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     Vetoquinol S.A.

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Aratana Therapeutics Inc.

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Elanco (Eli Lilly and Company)

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Dechra Pharmaceuticals Plc.

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Bayer AG

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     VetStem Biopharma

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

9.9.     Boehringer Ingelheim

9.9.1.  Business Overview

9.9.2.   Service Portfolio

9.9.3.  Strategic Developments

9.9.4.   Revenue and Market Share

10.    Global Canine Arthritis Treatment Market Competition, by Manufacturer

10.1. Global Canine Arthritis Treatment Revenue and Market Share by Manufacturer (2017-2017)

10.2. Global Canine Arthritis Treatment Price By Region (2017-2017)

10.3. Top 5 Canine Arthritis Treatment Manufacturer Market Share

10.4. Market Competition Trend

11.    Canine Arthritis Treatment Market Forecast (2017-2027)

11.1. Global Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

11.2. Canine Arthritis Treatment Market Forecast by Regions (2017-2027)

11.2.1.      North America Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.1.1. United States Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.1.2. Canada Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.1.3. Mexico Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.      Europe Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.1. Germany Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.2. France Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.3. UK Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.4. Russia Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.5. Italy Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.2.6. Rest of Europe Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.      Asia-Pacific Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.1. China Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.2. Japan Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.3. Korea Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.4. India Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.5. Southeast Asia Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.3.6. Rest of Asia-Pacific Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.4.      South America Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.4.1. Brazil Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.4.2. Argentina Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.4.3. Columbia Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.4.4. Rest of South America Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.      Middle East and Africa Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.1. Saudi Arabia Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.2. United Arab Emirates Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.3. Egypt Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.4. Nigeria Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.5. South Africa Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.6. Turkey Canine Arthritis Treatment Market Forecast (2017-2027)

11.2.5.7. Rest of Middle East and Africa Canine Arthritis Treatment Market Forecast (2017-2027)

11.3. Canine Arthritis Treatment Market Forecast by Treatment Type (2017-2027)

11.3.1.      Canine Arthritis Treatment Forecast by Treatment Type (2017-2027)

11.3.2.      Canine Arthritis Treatment Market Share Forecast by Treatment Type (2017-2027)

11.4. Canine Arthritis Treatment Market Forecast by Route Of Administration (2017-2027)

11.4.1.      Canine Arthritis Treatment Forecast by Route Of Administration (2017-2027)

11.4.2.      Canine Arthritis Treatment Market Share Forecast by Route Of Administration (2017-2027)

11.5. Canine Arthritis Treatment Market Forecast by End-Users (2017-2027)

11.5.1.      Canine Arthritis Treatment Forecast by End-Users (2017-2027)

11.5.2.      Canine Arthritis Treatment Market Share Forecast by End-Users (2017-2027)

List of Tables

12. List of Tables and Figures
Figure United States Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Canine Arthritis Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Canine Arthritis Treatment Revenue and Revenue Share by Treatment Type (2017-2018)
Figure Global Stem Cell Therapy Revenue and Growth Rate (2017-2018)
Figure Global Non-steroidal anti-inflammatory drugs Revenue and Growth Rate (2017-2018)
Figure Global Opioids Revenue and Growth Rate (2017-2018)
Table Global Canine Arthritis Treatment Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Injectable Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Table Global Canine Arthritis Treatment Revenue and Revenue Share by End-Users (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Veterinary Hospitals and Clinics Revenue and Growth Rate (2017-2018)
Figure Global E-commerce Revenue and Growth Rate (2017-2018)
Figure Global Drug Stores Revenue and Growth Rate (2017-2018)
Table Global Canine Arthritis Treatment Revenue by Regions (2017-2018)
Figure North America Canine Arthritis Treatment Growth Rate (2017-2018)
Figure North America Canine Arthritis Treatment Revenue and Growth Rate (2017-2018)
Figure North America Canine Arthritis Treatment by Countries (2017-2018)
Figure North America Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Canine Arthritis Treatment Growth Rate (2017-2018)
Figure United States Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Canada Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Mexico Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Europe Canine Arthritis Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Canine Arthritis Treatment by Countries (2017-2018)
Figure Europe Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Germany Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Canine Arthritis Treatment Growth Rate (2017-2018)
Figure France Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Canine Arthritis Treatment Growth Rate (2017-2018)
Figure UK Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Russia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Italy Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Rest of Europe Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Canine Arthritis Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Canine Arthritis Treatment by Countries (2017-2018)
Figure Asia-Pacific Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Canine Arthritis Treatment Growth Rate (2017-2018)
Figure China Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Japan Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Korea Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Canine Arthritis Treatment Growth Rate (2017-2018)
Figure India Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Southeast Asia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Canine Arthritis Treatment Growth Rate (2017-2018)
Figure South America Canine Arthritis Treatment Revenue and Growth Rate (2017-2018)
Figure South America Canine Arthritis Treatment by Countries (2017-2018)
Figure South America Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Brazil Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Argentina Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Columbia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Rest of South America Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Canine Arthritis Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Canine Arthritis Treatment by Countries (2017-2018)
Figure Middle East and Africa Canine Arthritis Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Canine Arthritis Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Egypt Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Nigeria Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Canine Arthritis Treatment Growth Rate (2017-2018)
Figure South Africa Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Turkey Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Canine Arthritis Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table Norbrook Laboratories Limited Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Zoetis Inc. Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Vetoquinol S.A. Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Aratana Therapeutics Inc. Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Elanco (Eli Lilly and Company) Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Dechra Pharmaceuticals Plc. Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer AG Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table VetStem Biopharma Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim Canine Arthritis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Canine Arthritis Treatment Market Share by Manufacturer
Figure Global Canine Arthritis Treatment Revenue and Market Share by Manufacturer
Table Global Canine Arthritis Treatment Price by Region (2017-2017)
Figure Top 5 Canine Arthritis Treatment Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Canine Arthritis Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Canine Arthritis Treatment Market Forecast by Regions (2018-2025)
Figure North America Canine Arthritis Treatment Market Forecast (2018-2025)
Figure United States Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Canada Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Mexico Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Europe Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Germany Canine Arthritis Treatment Market Forecast (2018-2025)
Figure France Canine Arthritis Treatment Market Forecast (2018-2025)
Figure UK Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Russia Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Italy Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Rest of Europe Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Canine Arthritis Treatment Market Forecast (2018-2025)
Figure China Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Japan Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Korea Canine Arthritis Treatment Market Forecast (2018-2025)
Figure India Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Southeast Asia Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Canine Arthritis Treatment Market Forecast (2018-2025)
Figure South America Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Brazil Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Argentina Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Columbia Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Rest of South America Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Canine Arthritis Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Egypt Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Nigeria Canine Arthritis Treatment Market Forecast (2018-2025)
Figure South Africa Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Turkey Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Canine Arthritis Treatment Market Forecast (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by Treatment Type (2018-2025)
Figure Global Canine Arthritis Treatment Market Share Forecast by Treatment Type (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by Treatment Type (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by Route Of Administration (2018-2025)
Figure Global Canine Arthritis Treatment Market Share Forecast by Route Of Administration (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by Route Of Administration (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by End-Users (2018-2025)
Figure Global Canine Arthritis Treatment Market Share Forecast by End-Users (2018-2025)
Figure Global Canine Arthritis Treatment Forecast by End-Users (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*